Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 4 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Hege F. Berg.

1. Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers.

Bischof K, Knappskog S, Hjelle SM, Stefansson I, Woie K, Salvesen HB, Gjertsen BT, Bjorge L.

Sci Rep. 2019 Mar 27;9(1):5244. doi: 10.1038/s41598-019-41706-z.

PMID: 30918304

2. Dasatinib as an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.

Brattås MK, Reikvam H, Tvedt THA, Bruserud Ø.

Expert Opin Investig Drugs. 2019 Mar 27. doi: 10.1080/13543784.2019.1597052. [Epub ahead of print]

PMID: 30916583

3. Immunosuppression And Immunotargeted Therapy In Acute Myeloid Leukemia – The Potential Use Of Checkpoint Inhibitors In Combination With Other Treatments.

Bruserud O, Leufven E.

Curr Med Chem. 2019 Mar 24. doi: 10.2174/0929867326666190325095853. [Epub ahead of print]

PMID: 30907305

4. Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C.: results from a European multicenter database (R.E.C.U.R.).

Dabestani S, Beisland C, Stewart GD, Bensalah K, Gudmundsson E, Lam TB, Gietzmann W, Zakikhani P, Marconi L, Fernandéz-Pello S, Monagas S, Williams SP, Powles T, Van Werkhoven E, Meijer R, Volpe A, Staehler M, Ljungberg B, Bex A.

Scand J Urol. 2019 Mar 25:1-7. doi: 10.1080/21681805.2019.1588919. [Epub ahead of print]

PMID: 30907214